AI assistant
SRF Ltd. — Capital/Financing Update 2023
Apr 12, 2023
61903_rns_2023-04-12_3c936163-51d3-4cfd-ab4f-4ce67fdacbe9.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [98 x 48] intentionally omitted <==
The Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited “Exchange Plaza” Ist Floor , New Trading Ring Rotunda Bandra-Kurla Complex Building, P.J. Towers Bandra (E) Dalal Street, Mumbai 400 051 Mumbai 400 001 Scrip Code-SRF Scrip Code- 503806 12.04.2023
SRF/SEC/BSE/NSE
Dear Sirs,
Subject: Commissioning and capitalisation of capital expenditure proposal approved by the Board
Dear Sir,
This is in continuation of our letter dated 25[th] January, 2022 informing Board’s approval for a project to create Pharma Intermediates Plant for undertaking precursor processes for production of Pharma products at Dahej.
It is hereby informed that project has been commissioned and capitalized on 12[th] April, 2023 at an aggregate cost of Rs. 223 Crores (approx.).
Thanking you,
Yours faithfully,
For SRF Limited
Rajat Digitally signed by Rajat Lakhanpal Lakhanpal Date: 2023.04.12 17:59:48 +05'30'
Rajat Lakhanpal Sr. Vice President (Corporate Compliance) & Company Secretary
SRF LIMITED Block-C Sector 45 Gurugram 122 003 Haryana India Tel: +91-124—4354400 Fax: +91-124—4354500 E-mail: [email protected] Website: www.srf.com Regd. Office: Unit No. 236 & 237, 2nd Floor. DLF Galleria, Mayur Place Noida Link Road Mayur Vihar Phase 1 Extension Delhi 110091
Corporate identity No. L181010L1970PLC005197
SRF - General [Restricted use] - This mail, document can be used by recipients for its intended purpose only.